. Modulators of KEAP-1 Activity as Potential Therapies for the Treatment of Neurodegenerative Disorders. ACS Med Chem Lett. 2019 Sep 12;10(9):1245-1246. Epub 2019 Aug 8 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.